CDEK
← All drugs Report issue

pha543613

Small moleculeexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

O=C(N[C@H]1CN2CCC1CC2)c1cc2ccoc2cn1
Mol. weight
271.32 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • n-(1-azabicyclo(2.2.2)oct-3-yl)furo(2,3-c)pyridine-5-carboxamide
  • pha543613
  • pha 543613
  • pha 543,613
  • pha-543613
  • pha-543613
  • pha-543613
  • pha-543,613